EGFR and adenocarcinoma: The 5.3% frequency of exon 14 MET mutations was derived from 150 adenocarcinomas carrying similar mean gene mutation frequencies as those previously reported in France for KRAS (23.3%), EGFR (9.3%), and BRAF (0.3%) [14].